Title: Recognition and Management of HLH
PRESENTER: Asaad Trabolsi M.D.
TITLE: Hematology/Oncology Fellow
AFFILIATION: Jackson Memorial Hospital and University of Miami, Sylvester Comprehensive Cancer Center
OBJECTIVES:
Title: Optimal Timing For Treatment Initiation In Advanced Solid Tumors
PRESENTER: Jose Monteiro, MD
TITLE: Hematology/Oncology Fellow
AFFILIATION: Jackson Memorial Hospital and University of Miami, Sylvester Comprehensive Cancer Center
OBJECTIVES:
FACULTY DISCLOSURE:
Dr. Trabolsi and Dr. Monteiro have indicated that they have no relevant financial relationships with commercial interests.
PLANNING COMMITTEE DISCLOSURE:
Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.
TARGET AUDIENCE:
Faculty, Primary Care Physicians, APRNs, PharmD
ACCREDITATION:
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This article was printed from The Miller School of Medicine Medical News
at the following URL: https://events.med.miami.edu/event/inter-cellular-mitochondria-shuffling-enhances-glioblastoma-tumorigenicity-2/
Copyright © 2024 University of Miami Health System